Skip to main content
Log in

Diagnosis, biology and treatment of hairy-cell leukaemia

  • REVIEW
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Hairy-cell leukaemia (HCL) is usually readily diagnosed by seeing typical hairy cells (HCs) in the blood film. The diagnosis is then confirmed by tartrate-resistant acid phosphatase staining, marker analysis, and bone marrow examination. HCs are clonal mature memory B cells with specific features of activation. This HC activation is responsible for many of the pathological features of the disease, including its distinctive bone marrow fibrosis, splenic red pulp invasion, and pseudo-sinus formation. Chlorodeoxyadenasine is the treatment of first choice. Deoxycoformycin and rituximab are useful for the treatment of relapsed/refractory disease. The nature of the primary oncogenic event(s) remains unknown and is the major unresolved issue in HCL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. J. Allsup.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allsup, D.J., Cawley, J.C. Diagnosis, biology and treatment of hairy-cell leukaemia. Clin Exp Med 4, 132–138 (2004). https://doi.org/10.1007/s10238-004-0046-z

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-004-0046-z

Key words

Navigation